These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lymphadenectomy with cystectomy: is it necessary and what is its extent? Ghoneim MA; Abol-Enein H Eur Urol; 2004 Oct; 46(4):457-61. PubMed ID: 15363560 [No Abstract] [Full Text] [Related]
5. [The importance of lymphadenectomy for muscle invasive transitional cell carcinoma of the human bladder - a review of the literature]. Alloussi SH; Huber S; Gakis G; Stenzl A; Schwentner C Aktuelle Urol; 2011 Mar; 42(2):115-21. PubMed ID: 21437835 [TBL] [Abstract][Full Text] [Related]
6. Separating surgical quality from causality--gaining perspective in the debate on lymph node count and extent of lymphadenectomy. Gilbert SM Cancer; 2008 Jun; 112(11):2331-3. PubMed ID: 18383514 [No Abstract] [Full Text] [Related]
7. A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients. Canter D; Guzzo TJ; Resnick MJ; Bergey MR; Sonnad SS; Tomaszewski J; VanArsdalen K; Malkowicz SB Urology; 2009 Jul; 74(1):161-5. PubMed ID: 19371932 [TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Thalmann G Eur Urol; 2010 Feb; 57(2):309. PubMed ID: 19766383 [No Abstract] [Full Text] [Related]
10. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Lotan Y Eur Urol; 2008 Mar; 53(3):579-80. PubMed ID: 17804152 [No Abstract] [Full Text] [Related]
12. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431 [TBL] [Abstract][Full Text] [Related]
13. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. Dretler SP; Ragsdale BD; Leadbetter WF Trans Am Assoc Genitourin Surg; 1972; 64():79-84. PubMed ID: 4654526 [No Abstract] [Full Text] [Related]
14. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265 [TBL] [Abstract][Full Text] [Related]
15. Inguinal metastasis of a bladder mixed carcinoma with predominant adenocarcinoma component. Hamano A; Udagawa K; Nomura S; Ishida T Scand J Urol Nephrol; 2006; 40(1):75-7. PubMed ID: 16452061 [TBL] [Abstract][Full Text] [Related]
17. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer. Ather MH; Alam Z; Jamshaid A; Siddiqui KM; Sulaiman MN Urol J; 2008; 5(2):94-8. PubMed ID: 18592461 [TBL] [Abstract][Full Text] [Related]
18. Re: patterns of initial transitional cell recurrence in patients after cystectomy. Zaghloul MS J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607 [No Abstract] [Full Text] [Related]
19. Robotic-assisted laparoscopic radical cystectomy: where do we stand? Novara G; Ficarra V Int J Clin Pract; 2009 Feb; 63(2):185-8. PubMed ID: 19196355 [No Abstract] [Full Text] [Related]
20. Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. Thompson IM J Urol; 2001 Aug; 166(2):630. PubMed ID: 11458100 [No Abstract] [Full Text] [Related] [Next] [New Search]